Maravai LifeSciences Balance Sheet
NASDAQ: MRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Maravai LifeSciences financial position
At the end of fiscal 2025, Maravai LifeSciences reported total assets of $770.6 million, down 23.6% from a year earlier against total liabilities of $397.9 million. Shareholders' equity stood at $212.4 million, or 27.6% of assets. The company held $216.9 million in cash and equivalents against $291.8 million of debt, a net debt position of $74.9 million.
The current ratio (current assets divided by current liabilities) was 6.60, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.37.
Summary generated from market data by MetaCap's automated system. Methodology
Maravai LifeSciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 216.89M | 322.40M | 574.96M | 632.14M | 551.27M | 236.18M | 24.70M |
| Receivables | 25.50M | 38.52M | 54.60M | 138.62M | 117.51M | 51.02M | — |
| Inventory | 40.49M | 50.08M | 51.40M | 43.15M | 51.56M | 33.30M | — |
| Total Current Assets | 296.25M | 429.15M | 699.91M | 847.90M | 740.04M | 331.60M | — |
| Property, Plant & Equipment | 151.48M | 164.47M | 162.90M | 52.69M | 46.33M | 101.31M | — |
| Goodwill | 129.43M | 159.88M | 326.03M | 283.67M | 152.77M | 224.28M | — |
| Intangible Assets | 151.54M | 194.96M | 220.99M | 216.66M | 117.57M | 177.66M | — |
| Total Assets | 770.58M | 1.01B | 1.49B | 2.28B | 1.92B | 1.27B | — |
| Accounts Payable | 2.91M | 11.96M | — | 5.99M | 8.15M | 8.17M | — |
| Short-Term Debt | 5.44M | 5.44M | 5.44M | 5.44M | 6.00M | 6.00M | — |
| Total Current Liabilities | 44.92M | 56.97M | 87.47M | 110.14M | 93.78M | 130.78M | — |
| Long-Term Debt | 286.33M | 290.49M | 518.71M | 522.00M | 524.59M | 528.61M | — |
| Total Liabilities | 397.87M | 431.04M | 697.57M | 1.38B | 1.37B | 1.12B | — |
| Shareholders' Equity | 212.38M | 325.29M | 416.75M | 545.22M | 315.50M | 88.51M | 144.63M |
| Retained Earnings | 10.12M | 140.89M | 285.74M | 404.77M | 184.56M | 854.00K | — |
| Total Debt | 291.77M | 295.93M | 524.15M | 527.44M | 530.59M | 534.61M | — |
| Net Cash (Debt) | -74.88M | 26.47M | 50.81M | 104.70M | 20.68M | -298.43M | 24.70M |
This table shows 7 annual periods of Maravai LifeSciences's balance sheet, from FY 2025 back to FY 2019, across 17 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow MRVI's reporting calendar. What is a balance sheet?